Jane Street’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$581K Sell
7,400
-2,900
-28% -$267K ﹤0.01% 7669
2026
Q2
$1.06M Sell
10,300
-7,800
-43% -$458K ﹤0.01% 6425
2026
Q1
$691K Buy
18,100
+8,000
+79% +$253K ﹤0.01% 7295
2025
Q4
$220K Buy
+10,100
New +$210K ﹤0.01% 9520
2025
Q2
– Sell
-14,800
Closed -$542K – 9580
2025
Q1
$542K Buy
+14,800
New +$509K ﹤0.01% 6713
2023
Q1
– Sell
-85,000
Closed -$2.73M – 9167
2022
Q4
$2.73M Buy
+85,000
New +$2.89M ﹤0.01% 3472
2021
Q3
– Sell
-7,400
Closed -$444K – 9886
2021
Q2
$444K Sell
7,400
-41,000
-85% -$2.05M ﹤0.01% 7459
2021
Q1
$2.28M Buy
+48,400
New +$1.99M ﹤0.01% 3756

Other funds holding ATEX

Jane Street's ATEX Position: Q3 2026 in Review

Jane Street increased its Anterix (ATEX) stake by 397% in Q3 2026, buying an estimated $6.39M and bringing the position to 86,935 shares worth $6.82M. The position accounts for ﹤0.01% of the portfolio, ranked #3291.

Jane Street first reported a position in ATEX in Q2 2020 and has held it in 21 quarters since. The position peaked at $16.1M in Q1 2026. 178 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • Jane Street held 86,935 shares of Anterix worth $6.82M as of Q3 2026.
  • Jane Street bought 69,429 Anterix shares in Q3 2026, an estimated $6.39M.
  • Anterix made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3291 holding.
  • Jane Street first reported a position in Anterix in Q2 2020 and has held it in 21 quarters since.
  • Jane Street's Anterix position peaked at $16.1M in Q1 2026.
  • 178 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.